NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.

XMAX

XMAX, Inc.

There isn't enough reported data to score XMAX yet.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

XMAX Fundamentals

MetricStatus
Healthy
Stable
Unavailable
Strong

XMAX's revenue and balance sheet are currently healthy, and its profitability is stable. There isn't enough data to rate its cash flow.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE has the edge over XMAX in the historical PE scenario, which offers more potential upside but is not a forecast.

XMAX PE Valuation

LevelPEPriceVs current
Current16x$6.56—
Cheap17x$6.78+3.4%
Fair21x$8.62+31%
Expensive21x$8.73+33%

Historical ranges are pointers, not guarantees.

XMAX's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

XMAX Forward outlook

There aren't enough analyst estimates for XMAX to show an outlook.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

There is not enough scenario data to compare NKE and XMAX's risk to reward.

XMAX Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $6.56 on Nov 12.

There is not enough scenario data to compare NKE and XMAX's risk to reward.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.

XMAX Earnings Per Share

Q3 2023: $-8.40Q4 2023: $-4.96Q1 2024: $-4.76Q2 2024: $-4.61Q3 2024: $-4.50Q4 2024: $-1.90Q1 2025: $-1.28Q2 2025: $-1.08Q3 2025: $-0.42Q4 2025: $-0.17Q1 2026: $-0.14Q2 2026: $0.41
Q3 2023: $-8.40Q4 2023: $-4.96Q1 2024: $-4.76Q2 2024: $-4.61Q3 2024: $-4.50Q4 2024: $-1.90Q1 2025: $-1.28Q2 2025: $-1.08Q3 2025: $-0.42Q4 2025: $-0.17Q1 2026: $-0.14Q2 2026: $0.41
QuarterTTM EPSYoY
Q2 2026$0.41+$1.49
Q1 2026-$0.14+$1.14
Q4 2025-$0.17+$1.73
Q3 2025-$0.42+$4.08
Q2 2025-$1.08+$3.53
Q1 2025-$1.28+$3.48
Q4 2024-$1.90+$3.06
Q3 2024-$4.50+$3.90

XMAX has the edge over NKE on earnings, with more consistent year-over-year improvement.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.

XMAX Quarterly Revenue

Q3 2023: $2MQ4 2023: $2MQ1 2024: $2MQ2 2024: $3MQ3 2024: $3MQ4 2024: $2MQ1 2025: $3MQ2 2025: $3MQ3 2025: $10MQ4 2025: $2MQ1 2026: $2MQ2 2026: $3M
Q3 2023: $2MQ4 2023: $2MQ1 2024: $2MQ2 2024: $3MQ3 2024: $3MQ4 2024: $2MQ1 2025: $3MQ2 2025: $3MQ3 2025: $10MQ4 2025: $2MQ1 2026: $2MQ2 2026: $3M
QuarterRevenueYoY
Q2 2026$2.7M+7.1%
Q1 2026$1.8M-32%
Q4 2025$1.8M-12%
Q3 2025$9.8M+273%
Q2 2025$2.6M-4.9%
Q1 2025$2.6M+11%
Q4 2024$2M-12%
Q3 2024$2.6M+5.6%

XMAX has the edge over NKE on sales, with more consistent year-over-year improvement.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

XMAX has the stronger cash trend. Its trailing FCF is up 57% versus its history, compared with NKE at down 52%.

XMAX Free Cash Flow

Q3 2023: --Q4 2023: −$3MQ1 2024: −$221,702Q2 2024: −$468,713Q3 2024: −$437,915Q4 2024: −$263,449Q1 2025: −$322,617Q2 2025: $92,513Q3 2025: −$2MQ4 2025: --Q1 2026: −$641,744Q2 2026: --
Q3 2023: --Q4 2023: −$3MQ1 2024: −$221,702Q2 2024: −$468,713Q3 2024: −$437,915Q4 2024: −$263,449Q1 2025: −$322,617Q2 2025: $92,513Q3 2025: −$2MQ4 2025: --Q1 2026: −$641,744Q2 2026: --
QuarterFree cash flowYoY
Q1 2026-$641.7K-$319.1K
Q3 2025-$1.9M-$1.5M
Q2 2025$92.5K+$561.2K
Q1 2025-$322.6K-$100.9K
Q4 2024-$263.4K+$2.8M
Q1 2024-$221.7K+$510.7K
Q4 2023-$3.1M-$1.2M
Q1 2023-$732.4K+$124.2K

XMAX has burned cash in almost every quarter: −$3M over the past year, against −$1M the year before.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has the edge over XMAX on shareholder dilution, with a more favorable share count trend.

XMAX Total Shares

Q3 2023: 2MQ1 2024: 2MQ2 2024: 3MQ3 2024: 3MQ4 2024: 4MQ1 2025: 10MQ2 2025: 14MQ3 2025: 18MQ1 2026: 45MQ2 2026: 61M
Q3 2023: 2MQ1 2024: 2MQ2 2024: 3MQ3 2024: 3MQ4 2024: 4MQ1 2025: 10MQ2 2025: 14MQ3 2025: 18MQ1 2026: 45MQ2 2026: 61M
PeriodChange %Net change
Quarterly+36%+16.2M shares
1 year+524%+51.2M shares
3 years+4302%+59.6M shares
5 years+5213%+59.9M shares
Available history+5210%+59.9M shares

XMAX has 61M diluted shares, up 524% from a year ago.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE's net debt is less than a year of its operating earnings (EBITDA).

XMAX Net Leverage

QuarterNet LeverageStatus
Q3 2019-1.0xNet Cash
Q2 2019-4.5xNet Cash

XMAX has more cash than debt.

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

XMAX Weekly Momentum

MetricValueStatus
RSI40.5Neutral
Stochastic30.6Neutral

XMAX's weekly RSI is 41 (neutral) and its Stochastic is 31 (neutral).

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.

XMAX PE vs Consumer Cyclical Sector

MetricXMAXSector medianRelative
PE16x18x11% below

XMAX has the edge over NKE on valuation relative to its sector.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

XMAX has stronger trend alignment. NKE is above 1 of 5 weekly averages versus XMAX above 1 of 4.

XMAX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$7.6414% below
20 week MA$8.2921% below
50 week MA$7.4812% below
100 week MA$4.8535% above

XMAX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 35% above its 100-week average.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has finished four years in a row lower, and it's down 38% so far in 2026.

XMAX Yearly ROI

YearStart priceEnd priceROI
2023$3.77$3.770%
2024$3.77$0.53-86%
2025$0.53$6.00+1032%
2026 YTD$6.00$6.56+9.3%

XMAX has the edge over NKE on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key